Phathom Pharmaceuticals (PHAT) announced the appointment of Ted Schroeder to its Board of Directors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHAT:
- Phathom Pharmaceuticals Announces Leadership Transition in 2025
- Phathom Pharmaceuticals appoints Basta as President, CEO
- Phathom Pharmaceuticals partners with Kenan Thompson for GERD awareness
- Biotech Alert: Searches spiking for these stocks today
- Phathom Pharmaceuticals: Favorable Risk/Reward Profile Amid Challenges and Growth Opportunities